Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Protexime 400 - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Protexime 400

Approved

STANDARD

Protexime 400

Swiss Pharma Pvt. Ltd🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 9ad85123cd5f4c1e
Company: Swiss Pharma Pvt. Ltd
Type: Standard

Approval Details

Approval Id: 9ad85123cd5f4c1e
Drug Approval Philippines Name: Protexime 400
Product Name: Protexime 400
Registration Number: DRP-7357-08
Brand Name: Protexime 400
Generic Name: Cefixime (as trihydrate)
Dosage Form: Dispersible Tablet
Dosage Strength: 400 mg
Manufacturer: Swiss Pharma Pvt. Ltd
Importer: Sanimed Pharmaceuticals Inc.
Distributor: Prohansen Pharma Phils. Inc
Issuance Date: 28 April 2024
Expiry Date: 26 February 2029
Pharmacologic Category: Antibacterial (Cephalosporin)
Classification: Prescription Drug (Rx)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

9ad85123cd5f4c1e

Type

Standard

Back to Philippines FDA Approvals